These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 15125308

  • 1. [Cardiac effects of antipsychotics: mechanism of arrhythmias and sudden cardiac death].
    Kecskeméti V.
    Neuropsychopharmacol Hung; 2004 Mar; 6(1):5-12. PubMed ID: 15125308
    [Abstract] [Full Text] [Related]

  • 2. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.
    Sala M, Coppa F, Cappucciati C, Brambilla P, d'Allio G, Caverzasi E, Barale F, De Ferrari GM.
    Curr Opin Investig Drugs; 2006 Mar; 7(3):256-63. PubMed ID: 16555686
    [Abstract] [Full Text] [Related]

  • 3. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval].
    Calderone V, Cavero I.
    Minerva Med; 2002 Jun; 93(3):181-97. PubMed ID: 12094149
    [Abstract] [Full Text] [Related]

  • 4. [Proarrhythmic (torsadogenic) effects of QT-prolonging non-antiarrhythmic drugs].
    Fazekas T, Liszkai G.
    Orv Hetil; 2005 Mar 06; 146(10):451-60. PubMed ID: 15835343
    [Abstract] [Full Text] [Related]

  • 5. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
    Ames D, Camm J, Cook P, Falkai P, Gury C, Hurley R, Johnson G, Piepho R, Vieweg V, Cardiac Safety in Schizophrenia Group.
    Encephale; 2002 Mar 06; 28(6 Pt 1):552-62. PubMed ID: 12506268
    [Abstract] [Full Text] [Related]

  • 6. Schizophrenia, antipsychotic drugs, and cardiovascular disease.
    Glassman AH.
    J Clin Psychiatry; 2005 Mar 06; 66 Suppl 6():5-10. PubMed ID: 16107178
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms and risks of electrocardiographic QT interval prolongation when using antipsychotic drugs.
    Vieweg WV.
    J Clin Psychiatry; 2002 Mar 06; 63 Suppl 9():18-24. PubMed ID: 12088172
    [Abstract] [Full Text] [Related]

  • 8. Long QT syndrome caused by noncardiac drugs.
    Viskin S, Justo D, Halkin A, Zeltser D.
    Prog Cardiovasc Dis; 2003 Mar 06; 45(5):415-27. PubMed ID: 12704598
    [Abstract] [Full Text] [Related]

  • 9. [Antipsychotic drugs and cardiovascular safety: current studies of prolonged QT interval and risk of ventricular arrhythmia].
    Gury C, Canceil O, Iaria P.
    Encephale; 2000 Mar 06; 26(6):62-72. PubMed ID: 11217540
    [Abstract] [Full Text] [Related]

  • 10. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil.
    Aiba T, Shimizu W, Inagaki M, Noda T, Miyoshi S, Ding WG, Zankov DP, Toyoda F, Matsuura H, Horie M, Sunagawa K.
    J Am Coll Cardiol; 2005 Jan 18; 45(2):300-7. PubMed ID: 15653031
    [Abstract] [Full Text] [Related]

  • 11. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.
    Haddad PM, Anderson IM.
    Drugs; 2002 Jan 18; 62(11):1649-71. PubMed ID: 12109926
    [Abstract] [Full Text] [Related]

  • 12. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
    Ahmad K, Dorian P.
    Europace; 2007 Sep 18; 9 Suppl 4():iv16-22. PubMed ID: 17766320
    [Abstract] [Full Text] [Related]

  • 13. [Psychopharmaceuticals and arrhythmias].
    Binggeli C, Candinas R, Brunckhorst C.
    Ther Umsch; 2004 Apr 18; 61(4):279-83. PubMed ID: 15137522
    [Abstract] [Full Text] [Related]

  • 14. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S, Marte F, Di Bella G, Currò A, Coglitore S.
    Int J Cardiol; 2008 Nov 12; 130(2):e71-3. PubMed ID: 18255176
    [Abstract] [Full Text] [Related]

  • 15. Antipsychotic medications and cardiac conduction risks.
    Roman M, Farmer SY.
    Issues Ment Health Nurs; 2010 Jan 12; 31(1):68-70. PubMed ID: 19951166
    [No Abstract] [Full Text] [Related]

  • 16. Drugs, QT interval abnormalities and ventricular arrhythmias.
    Thomas SH.
    Adverse Drug React Toxicol Rev; 1994 Jan 12; 13(2):77-102. PubMed ID: 7918900
    [No Abstract] [Full Text] [Related]

  • 17. Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions.
    Wysowski DK, Corken A, Gallo-Torres H, Talarico L, Rodriguez EM.
    Am J Gastroenterol; 2001 Jun 12; 96(6):1698-703. PubMed ID: 11419817
    [Abstract] [Full Text] [Related]

  • 18. Role of potassium currents in cardiac arrhythmias.
    Ravens U, Cerbai E.
    Europace; 2008 Oct 12; 10(10):1133-7. PubMed ID: 18653669
    [Abstract] [Full Text] [Related]

  • 19. Antipsychotic-induced sudden cardiac death: examination of an atypical reaction.
    Killeen MJ.
    Expert Opin Drug Saf; 2009 May 12; 8(3):249-52. PubMed ID: 19505259
    [Abstract] [Full Text] [Related]

  • 20. Pharmacologic agents associated with QT interval prolongation.
    Olsen KM.
    J Fam Pract; 2005 Jun 12; Suppl():S8-S14. PubMed ID: 15938993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.